Gayet, Odile <br/><br/>
A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.  [electronic resource] 

 -  Oncotarget  Jan 2015 
 - 746-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2685  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Azacitidine--pharmacology<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>DNA (Cytosine-5-)-Methyltransferase 1<br/>DNA (Cytosine-5-)-Methyltransferases--antagonists & inhibitors<br/>DNA Methyltransferase 3A<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Pancreatic Neoplasms--drug therapy<br/>Transcriptome<br/>Xenograft Model Antitumor Assays<br/>DNA Methyltransferase 3B